Members |
targetComponentId |
Mixed renal tubular acidosis |
Renal tubular acidosis |
Mixtard insulin adverse reaction |
Insulin adverse reaction |
Mixtard insulin allergy |
Allergy to insulin |
Moderate asthma |
Moderate asthma |
allergi mot isosorbiddinitrat med modifierad frisättning |
Allergy to isosorbide (finding) |
allergi mot isosorbidmononitrat med modifierad frisättning |
Allergy to isosorbide (finding) |
Moeller's glossitis |
Atrophy of tongue papillae |
Mohs' chemosurgery, fresh tissue technique |
Mohs' chemosurgery |
molgramostim 300 mikrogram, pulver till injektionsvätska, flaska |
Product containing only molgramostim in parenteral dose form (medicinal product form) |
molindonhydroklorid 20 mg/ml |
Product containing only molindone (medicinal product) |
Molluscum contagiosum subgroup virus |
Genus Molluscipoxvirus (organism) |
Molluscum contagiosum som involverar ögonlocken |
Infection of skin of eyelid caused by Molluscum contagiosum (disorder) |
Molluscum contagiosum with eyelid involvement |
Infection of skin of eyelid caused by Molluscum contagiosum (disorder) |
Mollusk |
Phylum Mollusca (organism) |
blötdjur, livsmedel |
Marine mollusk (substance) |
mometasonfuroat 200 mikrogram, lockaktiverad pulverinhalator |
Product containing only mometasone in pulmonary dose form (medicinal product form) |
monoartikulär juvenil reumatoid artrit |
Juvenile idiopathic arthritis, oligoarthritis (disorder) |
Monitoring of cardiac output by other technique |
Monitoring of cardiac output/cardiac index |
Monitoring patient temperature by nurse |
Monitoring of patient temperature |
Monoarticular juvenile rheumatoid arthritis |
Juvenile idiopathic arthritis, oligoarthritis (disorder) |
Monoclonal gammopathy |
Monoclonal gammopathy of undetermined significance |
Monocytic leukemia in remission |
Myeloid leukemia in remission |
Monocytoid B-cell lymphoma |
Marginal zone B-cell lymphoma |
Monooxygenase |
Monooxygenase (substance) |
Monosporium apiospermum |
Scedosporium boydii |
Monster NOS |
Congenital malformation |
missbildat foster med kranieanomalier |
Congenital anomaly of skull |
Monstrocellular sarcoma |
Giant cell glioblastoma |
Montelukast sodium 4mg oral granules |
Product containing precisely montelukast (as montelukast sodium) 4 milligram/1 sachet conventional release oral granules (clinical drug) |
Moraxella (Moraxella) phenylpyruvica |
Psychrobacter phenylpyruvicus |
Moraxella anatipestifer |
Riemerella anatipestifer |
hostdämpande morfinanpreparat |
Morphinan opioid (substance) |
biverkning av hostdämpande morfinanpreparat |
Morphinan opioid adverse reaction |
allergi mot hostdämpande morfinanpreparat |
Allergy to morphinan opioid |
morfin, icke läkemedel |
Morphine (substance) |
morfinhydroklorid 10 mg/ml, oral lösning |
Product containing precisely morphine sulfate 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
morfinsulfat 100 mg + naltrexonhydroklorid 4 mg, kapsel med modifierad frisättning |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
morfinsulfat 100 mg + naltrexonhydroklorid 4 mg, depåkapsel |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
morfinsulfat 100 mg, rektaltampong |
Morphine sulfate 100 mg rectal suppository |
morfinsulfat, granulat till suspension, dospåse 100 mg |
Product containing precisely morphine sulfate 5 milligram/1 milliliter conventional release oral suspension (clinical drug) |
morfinsulfat 10 mg/ml, liposominjektionspreparat med förlängd frisättning |
Morphine sulfate liposome 10 mg/mL solution for injection |
morfinsulfat, granulat till suspension, dospåse 200 mg |
Product containing precisely morphine sulfate 6.67 milligram/1 milliliter conventional release oral suspension (clinical drug) |
morfinsulfat 20 mg + naltrexonhydroklorid 800 mikrogram, kapsel med modifierad frisättning |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
morfinsulfat 20 mg + naltrexonhydroklorid 800 mikrogram, depåkapsel |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
morfinsulfat, granulat till suspension, dospåse 20 mg |
Product containing precisely morphine sulfate 2 milligram/1 milliliter conventional release oral suspension (clinical drug) |
morfinsulfat 30 mg + naltrexonhydroklorid 1,2 mg, kapsel med modifierad frisättning |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
morfinsulfat 30 mg + naltrexonhydroklorid 1,2 mg, depåkapsel |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
morfinsulfat 30 mg/5 ml, endosflaska för oralt bruk |
Product containing precisely morphine sulfate 6 milligram/1 milliliter conventional release oral solution (clinical drug) |
morfinsulfat, granulat till suspension, dospåse 30 mg |
Morphine sulfate 3 mg/mL oral suspension |
morfinsulfat 35 mg, rektaltampong |
Morphine sulfate 35 mg rectal suppository |
morfinsulfat 50 mg + naltrexonhydroklorid 2 mg, kapsel med modifierad frisättning |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
morfinsulfat 50 mg + naltrexonhydroklorid 2 mg, depåkapsel |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
morfinsulfat 50 mg, rektaltampong |
Morphine sulfate 50 mg rectal suppository |
morfinsulfat 60 mg + naltrexonhydroklorid 2,4 mg, kapsel med modifierad frisättning |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
morfinsulfat 60 mg + naltrexonhydroklorid 2,4 mg, depåkapsel |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
morfinsulfat, granulat till suspension, dospåse 60 mg |
Product containing precisely morphine sulfate 6 milligram/1 milliliter conventional release oral solution (clinical drug) |
morfinsulfat 75 mg, rektaltampong |
Morphine sulfate 75 mg rectal suppository |
morfinsulfat 80 mg + naltrexonhydroklorid 3,2 mg, kapsel med modifierad frisättning |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
morfinsulfat 80 mg + naltrexonhydroklorid 3,2 mg, depåkapsel |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
morfinsulfat 80 mg, kapsel med modifierad frisättning |
Product containing only morphine in oral dose form (medicinal product form) |
morfinsulfat 80 mg, depåkapsel |
Product containing only morphine in oral dose form (medicinal product form) |
Morphine tartrate+cyclizine |
Product containing cyclizine and morphine (medicinal product) |
Morphinian antitussive agent |
Morphinan opioid (substance) |
Mosquito-borne bunyavirus encephalitis |
Mosquito-borne orthobunyavirus encephalitis |
Mosquito-borne bunyavirus fever |
Mosquito-borne orthobunyavirus fever |
Mother currently breast-feeding |
Mother currently breastfeeding |
ammar för närvarande |
Mother currently breastfeeding |
Mouse mammary tumor virus |
Mouse mammary tumor virus |
flyttat annorstädes |
Moved elsewhere |
Moxifloxacin hydrochloride |
Product containing moxifloxacin (medicinal product) |
moxifloxacinhydroklorid 0,5 %, lösning för oftalmiskt bruk |
Product containing precisely moxifloxacin (as moxifloxacin hydrochloride) 5 milligram/1 milliliter conventional release eye solution (clinical drug) |
moxifloxacinhydroklorid 1,6 mg/ml, infusionsvätska, lösning, påse 250 ml |
Moxifloxacin (as moxifloxacin hydrochloride) 1.6 mg/mL solution for injection |
Mucinous cystadenoma, borderline malignancy |
Mucinous cystic tumor of borderline malignancy |
mucinös cystisk tumör med måttlig dysplasi |
Mucinous cystadenoma |
Mucoid otitis media |
Chronic mucoid otitis media |
Mucosal-associated lymphoid tissue (MALT) lymphoma |
Marginal zone B-cell lymphoma |
antiinfektivt medel för slemhinna |
Anti-infective agent (substance) |
Mulberry molar |
Moon's molar teeth |
multe eller mulle, livsmedel |
Mullet (substance) |
Multiceps |
Taenia |
Multiceps |
Taenia |
Multiceps brauni |
Taenia brauni |
Multiceps serialis |
Taenia serialis (organism) |
polycystisk njursjukdom |
Multicystic renal dysplasia |
Multiple closed fractures of skull and face with intracranial injury of other and unspecified nature |
Injury of head |
Multiple closed fractures of skull and face with other and unspecified intracranial hemorrhage |
Injury of head |
multipla komplikationer orsakade av diabetes mellitus |
Complication due to diabetes mellitus (disorder) |
malnutritionsrelaterad diabetes mellitus med multipla komplikationer |
Disorder due to malnutrition related diabetes mellitus |
multipla komplikationer vid diabetes mellitus typ 1 |
Disorder due to type 1 diabetes mellitus |
typ 2-diabetes mellitus med multipla komplikationer |
Disorder due to type 2 diabetes mellitus (disorder) |
multipla komplikationer vid diabetes mellitus typ 2 |
Disorder due to type 2 diabetes mellitus (disorder) |
Multiple endocrine deficiency syndrome, NEC |
Multiple endocrine deficiency syndrome |
Multiple myeloma |
Multiple myeloma |
multipelt myelom |
Plasma cell myeloma |
multipel lokalisation av icke-benbildande fibromatos |
Neurofibromatosis type 1 |
Multiple open fractures of skull and face with intracranial injury of other and unspecified nature |
Injury of head |
Multiple open fractures of skull and face with other and unspecified intracranial hemorrhage |
Injury of head |
cervikal spondylos på flera nivåer med myelopati |
Myelopathy due to multiple-level cervical spondylosis (disorder) |
cervikal spondylos på flera nivåer med radikulopati |
Radiculopathy due to multiple-level cervical spondylosis |
Mumps with other specified complication |
Mumps with complication |
har inte fått MMR-vaccination |
Measles mumps and rubella vaccination not done (situation) |